BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 29243839)

  • 1. Correlation of vitamin D and vitamin D receptor expression in patients with alopecia areata: a clinical paradigm.
    Daroach M; Narang T; Saikia UN; Sachdeva N; Sendhil Kumaran M
    Int J Dermatol; 2018 Feb; 57(2):217-222. PubMed ID: 29243839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum vitamin D level is related to disease severity in pediatric alopecia areata.
    Unal M; Gonulalan G
    J Cosmet Dermatol; 2018 Feb; 17(1):101-104. PubMed ID: 28447433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of vitamin D receptors in alopecia areata and androgenetic alopecia.
    Fawzi MM; Mahmoud SB; Ahmed SF; Shaker OG
    J Cosmet Dermatol; 2016 Dec; 15(4):318-323. PubMed ID: 27151518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of topical calcipotriol in management of alopecia areata: A pilot study.
    Narang T; Daroach M; Kumaran MS
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on Serum Vitamin D in Alopecia Areata Patients.
    Marahatta S; Agrawal S; Khan S
    J Nepal Health Res Counc; 2019 Apr; 17(1):21-25. PubMed ID: 31110371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential relationship between the canonical Wnt signalling pathway and expression of the vitamin D receptor in alopecia.
    Lim YY; Kim SY; Kim HM; Li KS; Kim MN; Park KC; Kim BJ
    Clin Exp Dermatol; 2014 Apr; 39(3):368-75. PubMed ID: 24635081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency in alopecia areata.
    Aksu Cerman A; Sarikaya Solak S; Kivanc Altunay I
    Br J Dermatol; 2014 Jun; 170(6):1299-304. PubMed ID: 24655364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of vitamin D status in alopecia areata.
    Gade VKV; Mony A; Munisamy M; Chandrashekar L; Rajappa M
    Clin Exp Med; 2018 Nov; 18(4):577-584. PubMed ID: 29869122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D Deficiency in Alopecia Areata.
    Ghafoor R; Anwar MI
    J Coll Physicians Surg Pak; 2017 Apr; 27(4):200-202. PubMed ID: 28492146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of vitamin D deficiency in patients with alopecia areata: a systematic review and meta-analysis.
    Lee S; Kim BJ; Lee CH; Lee WS
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1214-1221. PubMed ID: 29633370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Horizontal Sections of Scalp Biopsies in Differentiating between Androgenetic Alopecia and Alopecia Areata.
    Yadav D; Khandpur S; Ramam M; Singh MK; Sharma VK
    Dermatology; 2018; 234(3-4):137-147. PubMed ID: 30092597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum vitamin D and colonic vitamin D receptor in inflammatory bowel disease.
    Abreu-Delgado Y; Isidro RA; Torres EA; González A; Cruz ML; Isidro AA; González-Keelan CI; Medero P; Appleyard CB
    World J Gastroenterol; 2016 Apr; 22(13):3581-91. PubMed ID: 27053850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between vitamin D levels and alopecia areata.
    Mahamid M; Abu-Elhija O; Samamra M; Mahamid A; Nseir W
    Isr Med Assoc J; 2014 Jun; 16(6):367-70. PubMed ID: 25058999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein as a novel biomarker for vitamin D deficiency in alopecia areata.
    AbdElneam AI; Al-Dhubaibi MS; Bahaj SS; Mohammed GF; Alantry AK; Atef LM
    Skin Res Technol; 2024 Mar; 30(3):e13657. PubMed ID: 38528743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular retinol-binding protein-1 expression increases with increasing clinical severity of alopecia areata.
    Elmaadawy E; Elgarhy LH; Shareef M
    J Cosmet Dermatol; 2019 Apr; 18(2):659-664. PubMed ID: 30556317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of vitamin D, vitamin D-binding protein and vitamin D receptor in migraine patients from central Anatolia region.
    Celikbilek A; Gocmen AY; Zararsiz G; Tanik N; Ak H; Borekci E; Delibas N
    Int J Clin Pract; 2014 Oct; 68(10):1272-7. PubMed ID: 24837712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escalating dosimetry of UVA-1 in the treatment of alopecia areata.
    Herz-Ruelas ME; Gomez-Flores M; Miranda-Maldonado I; Welsh E; Ocampo-Candiani J; Welsh O
    Int J Dermatol; 2017 Jun; 56(6):653-659. PubMed ID: 28233311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between serum IL-17A level and SALT score in patients with alopecia areata before and after NB-UVB therapy.
    Morsy H; Maher R; Negm D
    J Cosmet Dermatol; 2018 Jun; 17(3):533-537. PubMed ID: 29707896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of macrophage migration inhibitory factor (MIF) levels in serum and lesional skin of patients with alopecia areata.
    Salem SA; Asaad MK; Elsayed SB; Sehsah HM
    Int J Dermatol; 2016 Dec; 55(12):1357-1361. PubMed ID: 27420731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.